 MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.

Articles

The combination approach may significantly reduce over-detection while providing noninferior detection of clinically significant prostate cancer.

Stockholm3 with MRI-Targeted Biopsy Noninferior to PSA for Prostate Cancer Screening

The algorithm is the first step towards developing an artificial intelligence-augmented radiology workflow that can support image interpretation to improve diagnosis and prognosis.

Algorithm Can Classify Major Intracranial Tumor Types from a Single MRI Scan 

Training sets from different vendors may be required to ensure scanner-specific sensitivity.  

AI Can Accurately Assign Contrast Use in Prostate MRI  

Whitney J. Palmer has been with Diagnostic Imaging since 2011, serving as the Senior Editor since November 2019. She has 20 years experience in healthcare and academic medicine reporting.

The clear cell likelihood score can help providers determine the growth rate of masses that could be cancerous.

MRI-Derived Score Helps Determine Renal Mass Growth Rate

Including MRI leads to more quality-adjusted life years.

Adding MRI Improves Cost-Effectiveness of Prostate Cancer Active Surveillance

The potential opportunities are numerous for virtual biopsies, radiomics, and radiogenomics.

Virtual Biopsy: A Safer Future for Cancer Management 

Relying on MRI images rather than PSA screening can reduce unnecessary biopsies and identification of clinically insignificant cancers.

MRI Cuts Prostate Cancer Screening Over-Diagnosis by Half

Using a deep convolutional neural network can improve providers’ ability to predict how patients with hepatocellular carcinoma will respond to Y90-RE treatment, enabling them to offer additional therapies, if necessary.

Deep Learning Helps Predict Y90-RE Response in HCC Patients

Case Western Reserve University biomedical engineer developed a contrast agent that could allow for non-invasive disease detection.
 


FDA Approves Tumor-Based MRI Contrast Agent for Prostate Cancer Detection

Investigators used a hypothetical cohort of men with prostate cancer to test the benefits associated with MRI imaging before biopsy in regard to age-based and risk-stratified screening.

Oncology MRI